MENU
+Compare
QGEN
Stock ticker: NYSE
AS OF
Sep 15, 02:03 PM (EDT)
Price
$45.45
Change
+$0.17 (+0.38%)
Capitalization
9.82B

QGEN Qiagen N.V. Forecast, Technical & Fundamental Analysis

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins... Show more

QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for QGEN with price predictions
Sep 12, 2025

QGEN in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 28, 2025

QGEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where QGEN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for QGEN's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where QGEN advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on QGEN as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

QGEN moved below its 50-day moving average on August 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for QGEN crossed bearishly below the 50-day moving average on August 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for QGEN entered a downward trend on September 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.801) is normal, around the industry mean (22.742). P/E Ratio (26.784) is within average values for comparable stocks, (138.399). QGEN's Projected Growth (PEG Ratio) (0.313) is slightly lower than the industry average of (1.684). Dividend Yield (0.005) settles around the average of (0.022) among similar stocks. P/S Ratio (4.808) is also within normal values, averaging (9.726).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. QGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

QGEN is expected to report earnings to fall 2.05% to 58 cents per share on November 04

Qiagen N.V. QGEN Stock Earnings Reports
Q3'25
Est.
$0.59
Q2'25
Est.
$0.60
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
The last earnings report on August 05 showed earnings per share of 60 cents, meeting the estimate of 60 cents. With 230.76K shares outstanding, the current market capitalization sits at 9.82B.
A.I. Advisor
published General Information

General Information

a manufacturer of sample and assay technology products for preanalytical sample preparations

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Hulsterweg 82
Phone
+31 773556600
Employees
6000
Web
https://www.qiagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CADRX24.590.06
+0.24%
Columbia Large Cap Growth Opp Inst2
VSTSX310.88-0.48
-0.15%
Vanguard Total Stock Mkt Idx Instl Sel
IRGTX10.46-0.03
-0.29%
VY® CBRE Global Real Estate S
LIRSX9.77-0.03
-0.31%
Lord Abbett International Value R4
SVFFX82.72-1.05
-1.25%
Smead Value I1

QGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with DHR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
-1.69%
DHR - QGEN
66%
Loosely correlated
-2.62%
RVTY - QGEN
61%
Loosely correlated
-3.28%
TMO - QGEN
59%
Loosely correlated
-2.43%
A - QGEN
59%
Loosely correlated
-2.75%
MTD - QGEN
58%
Loosely correlated
-1.81%
More

Groups containing QGEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
-1.69%
QGEN
(2 stocks)
74%
Closely correlated
-0.32%